Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 16 September 2027
- Last conf. stmt
- 2 September 2026
Shield Therapeutics PLC
- Incorporated
- 3 September 2015 (11 years)
- Industry
- Other human health activities (86900)
- Directors
- Rudolf Stefan WidmannMaria Fabiana Lacerca-AllenKarl Anders Lundstrom
- Owned by
- Aop Health International Management AG
- Accounts type
- Group
- Region
- North East
- Address
- Northern Design Centre Studio 63rd FloorBaltic Business QuarterGateshead QuaysNE8 3DF
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 7 active
Officer details are public data from the Companies House register.
Widmann, Rudolf Stefan, Dr
Director · Appointed 3 July 2024
Austrian
Born March 1957 (69)
Lacerca-Allen, Maria Fabiana
Director · Appointed 10 May 2021
Argentine,American
Born April 1967 (59)
Lundstrom, Karl Anders
Director · Appointed 10 May 2021
Swedish,American
Born May 1962 (64)
Schweiger, Christian Karl Kurt, Dr
Director · Appointed 26 June 2020
German,Swiss
Born July 1966 (60)
Hasler, Hans Peter
Director · Appointed 26 July 2018
Swiss
Born February 1956 (70)
Huntington-Bailey, Lucy Kate
Secretary · Appointed 1 September 2017
Llewellyn-Davies, Peter
Director · Appointed 26 February 2016
British
Born April 1958 (68)
Officer history (10 former)
24 July 2024
3 July 2024
Appointed Widmann, Rudolf Stefan, Dr as Director
30 September 2021
18 June 2021
17 June 2021
Resigned Hoffmann, Rolf Karl Heinz as Director
10 May 2021
Appointed Lacerca-Allen, Maria Fabiana as Director
10 May 2021
Appointed Lundstrom, Karl Anders as Director
26 June 2020
Appointed Schweiger, Christian Karl Kurt, Dr as Director
18 June 2020
Resigned Karis, James as Director
27 April 2020
21 April 2020
26 July 2018
Appointed Hasler, Hans Peter as Director
27 June 2018
Resigned Heath, Andrew John William as Director
6 April 2018
Appointed Hoffmann, Rolf Karl Heinz as Director
14 September 2017
1 September 2017
Appointed Huntington-Bailey, Lucy Kate as Secretary
1 September 2017
1 May 2017
27 January 2017
Resigned Jones, Richard as Secretary
27 January 2017
27 January 2017
26 February 2016
Appointed Karis, James as Director
26 February 2016
Appointed Llewellyn-Davies, Peter as Director
26 February 2016
Appointed Heath, Andrew John William as Director
3 September 2015
Appointed Jones, Richard as Secretary
3 September 2015
3 September 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Aop Health International Management AG
Corporate entity · Notified 1 August 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
Public Limited Company
Reg. no. Fl-0002.512.656-2
Holdings 2
Companies where Shield Therapeutics PLC is registered as a person with significant control
Owns 75–100% of shares
In liquidation
Has significant influence or control
Active
Former controllers (1)
1 September 2022
Ceased Nestle SA — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 30 October 2026 | Statement of capital following an allotment of shares | |||
| 23 October 2026 | Other filing | |||
| 23 October 2026 | Other filing | |||
| 29 September 2026 | Statement of capital following an allotment of shares | |||
| 24 September 2026 | Statement of capital following an allotment of shares |
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →